{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:51:34Z","timestamp":1760921494863,"version":"build-2065373602"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41417-025-00952-2","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T17:58:13Z","timestamp":1755367093000},"page":"1031-1041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncSNHGs: new targets in osteosarcoma"],"prefix":"10.1038","volume":"32","author":[{"given":"Yining","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfa","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-9136","authenticated-orcid":false,"given":"Jiaming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02105-9","volume":"23","author":"S Yu","year":"2024","unstructured":"Yu S, Yao X. Advances on immunotherapy for osteosarcoma. Mol Cancer. 2024;23:192.","journal-title":"Mol Cancer"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/ijc.33673","volume":"149","author":"GA Rojas","year":"2021","unstructured":"Rojas GA, Hubbard AK, Diessner BJ, Ribeiro KB, Spector LG. International trends in incidence of osteosarcoma (1988\u20132012). Int J Cancer. 2021;149:1044\u201353.","journal-title":"Int J Cancer"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, et al. Osteosarcoma. Nat Rev Dis Prim. 2022;8:77.","journal-title":"Nat Rev Dis Prim"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06752-0","volume":"15","author":"CH Hou","year":"2024","unstructured":"Hou CH, Chen WL, Lin CY. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib. Cell Death Dis. 2024;15:1\u201313.","journal-title":"Cell Death Dis"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","volume":"385","author":"PS Meltzer","year":"2021","unstructured":"Meltzer PS, Helman LJ. New horizons in the treatment of osteosarcoma. N Engl J Med. 2021;385:2066\u201376.","journal-title":"N Engl J Med"},{"key":"952_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1498060","volume":"15","author":"H Lian","year":"2025","unstructured":"Lian H, Zhang J, Hou S, Ma S, Yu J, Zhao W, et al. Immunotherapy of osteosarcoma based on immune microenvironment modulation. Front Immunol. 2025;15:1498060.","journal-title":"Front Immunol"},{"key":"952_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024;5:101728.","journal-title":"Cell Rep Med"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-36826-0","volume":"14","author":"W Barczak","year":"2023","unstructured":"Barczak W, Carr SM, Liu G, Munro S, Nicastri A, Lee LN, et al. Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nat Commun. 2023;14:1\u201317.","journal-title":"Nat Commun"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tips.2022.01.008","volume":"43","author":"TR Mercer","year":"2022","unstructured":"Mercer TR, Munro T, Mattick JS. The potential of long noncoding RNA therapies. Trends Pharm Sci. 2022;43:269\u201380.","journal-title":"Trends Pharm Sci"},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.omtn.2020.07.005","volume":"21","author":"D Fu","year":"2020","unstructured":"Fu D, Shi Y, Liu JB, Wu TM, Jia CY, Yang HQ, et al. Targeting long non-coding RNA to therapeutically regulate gene expression in cancer. Mol Ther Nucleic Acids. 2020;21:712\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.omtn.2023.07.009","volume":"33","author":"C Wei","year":"2023","unstructured":"Wei C, Xu Y, Shen Q, Li R, Xiao X, Saw PE, et al. Role of long non-coding RNAs in cancer: from subcellular localization to nanoparticle-mediated targeted regulation. Mol Ther Nucleic Acids. 2023;33:774\u201393.","journal-title":"Mol Ther Nucleic Acids"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.ymthe.2021.03.017","volume":"29","author":"Y Xu","year":"2021","unstructured":"Xu Y, Qiu M, Shen M, Dong S, Ye G, Shi X, et al. The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther. 2021;29:2209\u201318.","journal-title":"Mol Ther"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.omtn.2020.09.039","volume":"23","author":"AS Pathania","year":"2021","unstructured":"Pathania AS, Challagundla KB. Exosomal long non-coding RNAs: emerging players in the tumor microenvironment. Mol Ther Nucleic Acids. 2021;23:1371\u201383.","journal-title":"Mol Ther Nucleic Acids"},{"key":"952_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-021-00245-5","volume":"6","author":"C Badowski","year":"2022","unstructured":"Badowski C, He B, Garmire LX. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the good, the bad and the beauty. NPJ Precis Oncol. 2022;6:1\u201318.","journal-title":"NPJ Precis Oncol"},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"1143980","DOI":"10.3389\/fimmu.2023.1143980","volume":"14","author":"H Xiao","year":"2023","unstructured":"Xiao H, Feng X, Liu M, Gong H, Zhou X. SnoRNA and lncSNHG: advances of nucleolar small RNA host gene transcripts in anti-tumor immunity. Front Immunol. 2023;14:1143980.","journal-title":"Front Immunol"},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/genes13122268","volume":"13","author":"AQ Tan","year":"2022","unstructured":"Tan AQ, Zheng YF. The roles of SNHG family in osteoblast differentiation. Genes. 2022;13:2268.","journal-title":"Genes"},{"key":"952_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108055","volume":"26","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wang G, Wang Y, Liu J, Ma G, Du J. Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response. iScience. 2023;26:108055.","journal-title":"iScience"},{"key":"952_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144724","volume":"749","author":"YH Li","year":"2020","unstructured":"Li YH, Hu YQ, Wang SC, Li Y, Chen DM. LncRNA SNHG5: a new budding star in human cancers. Gene. 2020;749:144724.","journal-title":"Gene"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3724\/abbs.2021014","volume":"54","author":"Q Liu","year":"2022","unstructured":"Liu Q, Luo J, Wang H, Zhang L, Jin G. SNHG1 functions as an oncogenic lncRNA and promotes osteosarcoma progression by up-regulating S100A6 via miR-493-5p. Acta Biochim Biophys Sin. 2022;54:137\u201347.","journal-title":"Acta Biochim Biophys Sin"},{"key":"952_CR20","doi-asserted-by":"publisher","first-page":"18571","DOI":"10.18632\/aging.103849","volume":"12","author":"HL Zheng","year":"2020","unstructured":"Zheng HL, Yang RZ, Xu WN, Liu T, Chen PB, Zheng XF, et al. Characterization of LncRNA SNHG22 as a protector of NKIRAS2 through miR-4492 binding in osteosarcoma. Aging. 2020;12:18571\u201387.","journal-title":"Aging"},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/ijms25052923","volume":"25","author":"M Huo","year":"2024","unstructured":"Huo M, Rai SK, Nakatsu K, Deng Y, Jijiwa M. Subverting the canon: novel cancer-promoting functions and mechanisms for snoRNAs. Int J Mol Sci. 2024;25:2923.","journal-title":"Int J Mol Sci"},{"key":"952_CR22","doi-asserted-by":"crossref","unstructured":"Hu X, Cui W, Liu M, Zhang F, Zhao Y.Zhang M, et al. SnoRNAs: the promising targets for anti-tumor t herapy. J Pharm Anal. 2024;14:101064.","DOI":"10.1016\/j.jpha.2024.101064"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fonc.2020.00389","volume":"10","author":"AA Zimta","year":"2020","unstructured":"Zimta AA, Tigu AB, Braicu C, Stefan C, Ionescu C, Berindan-Neagoe I. An emerging class of long non-coding RNA with oncogenic role arises from the snoRNA host genes. Front Oncol. 2020;10:389.","journal-title":"Front Oncol"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146:353\u20138.","journal-title":"Cell"},{"key":"952_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108695","volume":"112","author":"S Zheng","year":"2019","unstructured":"Zheng S, Jiang F, Ge D, Tang J, Chen H, Yang J, et al. LncRNA SNHG3\/miRNA-151a-3p\/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother. 2019;112:108695.","journal-title":"Biomed Pharmacother"},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.4149\/neo_2022_220228N218","volume":"69","author":"CJ Bai","year":"2022","unstructured":"Bai CJ, Gao T, Liu JY, Li S, Wang XY, Fan ZF. SNHG9\/miR-214-5p\/SOX4 feedback loop regulates osteosarcoma progression. Neoplasma. 2022;69:1175\u201384.","journal-title":"Neoplasma"},{"key":"952_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2174\/1386207326666230602122618","volume":"27","author":"N Wan","year":"2024","unstructured":"Wan N, Liu Q, Shi J, Wang S. LncRNA SNHG25 predicts poor prognosis and promotes progression in osteosarcoma via the miR-497-5p\/SOX4 axis. Comb Chem High Throughput Screen. 2024;27:725\u201344.","journal-title":"Comb Chem High Throughput Screen"},{"key":"952_CR28","first-page":"3602","volume":"23","author":"GD Zhang","year":"2019","unstructured":"Zhang GD, Gai PZ, Liao GY, Li Y. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1. Eur Rev Med Pharm Sci. 2019;23:3602\u201310.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"952_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01155-z","volume":"19","author":"M Cheray","year":"2020","unstructured":"Cheray M, Etcheverry A, Jacques C, Pacaud R, Bougras-Cartron G, Aubry M, et al. Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme. Mol Cancer. 2020;19:36.","journal-title":"Mol Cancer"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2011.354","volume":"31","author":"P Lopez-Serra","year":"2011","unstructured":"Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 2011;31:1609\u201322.","journal-title":"Oncogene"},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13018-020-01865-6","volume":"15","author":"P He","year":"2020","unstructured":"He P, Xu Y, Wang Z. LncRNA SNHG10 increases the methylation of miR-218 gene to promote glucose uptake and cell proliferation in osteosarcoma. J Orthop Surg Res. 2020;15:353.","journal-title":"J Orthop Surg Res"},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.abb.2018.03.036","volume":"646","author":"J Ruan","year":"2018","unstructured":"Ruan J, Zheng L, Hu N, Guan G, Chen J, Zhou X, et al. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2. Arch Biochem Biophys. 2018;646:128\u201336.","journal-title":"Arch Biochem Biophys"},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"205873841882074","DOI":"10.1177\/2058738418820743","volume":"33","author":"J Chen","year":"2019","unstructured":"Chen J, Wu Z, Zhang Y. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. Int J Immunopathol Pharm. 2019;33:2058738418820743.","journal-title":"Int J Immunopathol Pharm"},{"key":"952_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12515","volume":"51","author":"R Xu","year":"2018","unstructured":"Xu R, Feng F, Yu X, Liu Z, Lao L. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma. Cell Prolif. 2018;51:e12515.","journal-title":"Cell Prolif"},{"key":"952_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1515\/biol-2020-0039","volume":"15","author":"X Chen","year":"2020","unstructured":"Chen X, Xu H. LncRNA SNHG15 regulates osteosarcoma progression in vitro and in vivo via sponging miR-346 and regulating TRAF4 expression. Open Life Sci. 2020;15:423\u201336.","journal-title":"Open Life Sci"},{"key":"952_CR36","first-page":"1157","volume":"43","author":"R Deng","year":"2019","unstructured":"Deng R, Zhang J, Chen J. lncRNA SNHG1 negatively regulates miRNA\u2011101\u20113p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma. Int J Mol Med. 2019;43:1157\u201366.","journal-title":"Int J Mol Med"},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.08.025","volume":"107","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wang Z, Liu J, Yang H. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1. Biomed Pharmacother. 2018;107:598\u2013605.","journal-title":"Biomed Pharmacother"},{"key":"952_CR38","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.bbrc.2017.12.047","volume":"495","author":"S Zhou","year":"2018","unstructured":"Zhou S, Yu L, Xiong M, Dai G. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating NotcH2 by sponging miR-195-5p. Biochem Biophys Res Commun. 2018;495:1822\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"952_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bbrc.2020.01.016","volume":"523","author":"XK Hou","year":"2020","unstructured":"Hou XK, Mao JS. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p\/FBXO22 axis. Biochem Biophys Res Commun. 2020;523:766\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"952_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07933-2","volume":"21","author":"X Xiao","year":"2021","unstructured":"Xiao X, Jiang G, Zhang S, Hu S, Fan Y, Li G, et al. LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p. BMC Cancer. 2021;21:355.","journal-title":"BMC Cancer"},{"key":"952_CR41","first-page":"3476","volume":"12","author":"H Hao","year":"2020","unstructured":"Hao H, Wang L, Liu Q, Wu D, Xing H. LncRNA small nucleolar RNA host gene 8 promotes cell growth and migration of osteosarcoma in vitro and in vivo by functioning as a ceRNA of microRNA-876-5p. Am J Transl Res. 2020;12:3476\u201388.","journal-title":"Am J Transl Res"},{"key":"952_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2017.06.009","volume":"405","author":"N Jiang","year":"2017","unstructured":"Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu J, et al. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 2017;405:46\u201355.","journal-title":"Cancer Lett"},{"key":"952_CR43","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/iub.1922","volume":"70","author":"J Zhang","year":"2018","unstructured":"Zhang J, Ju C, Zhang W, Xie L. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma. IUBMB Life. 2018;70:1115\u201321.","journal-title":"IUBMB Life"},{"key":"952_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01553-4","volume":"16","author":"Z Tang","year":"2023","unstructured":"Tang Z, Feng H, Shu L, Guo M, Qi B, Pu L, et al. Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment. BMC Med Genomics. 2023;16:115.","journal-title":"BMC Med Genomics"},{"key":"952_CR45","doi-asserted-by":"publisher","first-page":"096368972095309","DOI":"10.1177\/0963689720953093","volume":"29","author":"J Liu","year":"2020","unstructured":"Liu J, Chen M, Ma L, Dang X, Du G. LncRNA GAS5 suppresses the proliferation and invasion of osteosarcoma cells via the miR-23a-3p\/PTEN\/PI3K\/AKT pathway. Cell Transpl. 2020;29:096368972095309.","journal-title":"Cell Transpl"},{"key":"952_CR46","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1002\/jcb.26145","volume":"118","author":"K Ye","year":"2017","unstructured":"Ye K, Wang S, Zhang H, Han H, Ma B, Nan W. Long noncoding RNA GAS5 suppresses cell growth and epithelial-mesenchymal transition in osteosarcoma by regulating the miR-221\/ARHI pathway. J Cell Biochem. 2017;118:4772\u201381.","journal-title":"J Cell Biochem"},{"key":"952_CR47","first-page":"517","volume":"34","author":"GB Zhong","year":"2020","unstructured":"Zhong GB, Jiang CQ, Yu XS, Liu ZD, Wang WL, Xu RD. Long noncoding RNA SNHG8 promotes the proliferation of osteosarcoma cells by downregulating miR-542-3p. J Biol Regul Homeost Agents. 2020;34:517\u201324.","journal-title":"J Biol Regul Homeost Agents"},{"key":"952_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0794-1","volume":"19","author":"X Zhu","year":"2019","unstructured":"Zhu X, Yang G, Xu J, Zhang C. Silencing of SNHG6 induced cell autophagy by targeting miR-26a-5p\/ULK1 signaling pathway in human osteosarcoma. Cancer Cell Int. 2019;19:82.","journal-title":"Cancer Cell Int"},{"key":"952_CR49","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.3390\/cancers15205108","volume":"15","author":"BK Nirala","year":"2023","unstructured":"Nirala BK, Yamamichi T, Petrescu DI, Shafin TN, Yustein JT. Decoding the impact of tumor microenvironment in osteosarcoma progression and metastasis. Cancers. 2023;15:5108.","journal-title":"Cancers"},{"key":"952_CR50","doi-asserted-by":"publisher","first-page":"e23031","DOI":"10.1002\/jbt.23031","volume":"36","author":"J Ge","year":"2022","unstructured":"Ge J, Liu M, Zhang Y, Xie L, Shi Z, Wang G. SNHG10\/miR-141-3p\/WTAP axis promotes osteosarcoma proliferation and migration. J Biochem Mol Toxicol. 2022;36:e23031.","journal-title":"J Biochem Mol Toxicol"},{"key":"952_CR51","first-page":"77","volume":"52","author":"J Wang","year":"2018","unstructured":"Wang J, Cao L, Wu J, Wang Q. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol. 2018;52:77\u201388.","journal-title":"Int J Oncol"},{"key":"952_CR52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/etm.2021.9756","volume":"21","author":"Z Li","year":"2021","unstructured":"Li Z, Wang X, Liang S. Long non-coding RNA small nucleolar RNA host gene 1 knockdown suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating microRNA-424-5p\/FGF2 in vitro. Exp Ther Med. 2021;21:325.","journal-title":"Exp Ther Med"},{"key":"952_CR53","doi-asserted-by":"publisher","first-page":"144145","DOI":"10.1016\/j.gene.2019.144145","volume":"726","author":"N Xu","year":"2020","unstructured":"Xu N, Xu J, Zuo Z, Liu Y, Yan F, Han C. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p. Gene. 2020;726:144145.","journal-title":"Gene"},{"key":"952_CR54","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1007\/s13277-015-4256-7","volume":"37","author":"W Ruan","year":"2016","unstructured":"Ruan W, Wang P, Feng S, Xue Y, Li Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol. 2016;37:4065\u201373.","journal-title":"Tumour Biol"},{"key":"952_CR55","first-page":"96","volume":"23","author":"SN Zheng","year":"2019","unstructured":"Zheng SN, Ge DW, Tang J, Yang J, Yan JW, Qiu JJ, et al. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p. Eur Rev Med Pharm Sci. 2019;23:96\u2013104.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"952_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108798","volume":"114","author":"X Wang","year":"2019","unstructured":"Wang X, Hu K, Chao Y, Wang L. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301\/BCL9 axis. Biomed Pharmacother. 2019;114:108798.","journal-title":"Biomed Pharmacother"},{"key":"952_CR57","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1177\/0960327120937330","volume":"39","author":"S Zhao","year":"2020","unstructured":"Zhao S, Xiong W, Xu K. MiR-663a, regulated by lncRNA GAS5, contributes to osteosarcoma development through targeting MYL9. Hum Exp Toxicol. 2020;39:1607\u201318.","journal-title":"Hum Exp Toxicol"},{"key":"952_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41422-020-0370-1","volume":"30","author":"K Matsuoka","year":"2020","unstructured":"Matsuoka K, Bakiri L, Wolff LI, Linder M, Mikels-Vigdal A, Pati\u00f1o-Garc\u00eda A, et al. Wnt signaling and Loxl2 promote aggressive osteosarcoma. Cell Res. 2020;30:885\u2013901.","journal-title":"Cell Res"},{"key":"952_CR59","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.omtn.2020.10.010","volume":"22","author":"S Zhu","year":"2020","unstructured":"Zhu S, Liu Y, Wang X, Wang J, Xi G. lncRNA SNHG10 promotes the proliferation and invasion of osteosarcoma via wnt\/\u03b2-catenin signaling. Mol Ther Nucleic Acids. 2020;22:957\u201370.","journal-title":"Mol Ther Nucleic Acids"},{"key":"952_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2017.11.012","volume":"495","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Jiang C, Fang J. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B\/wnt\/\u03b2-catenin pathway. Biochem Biophys Res Commun. 2018;495:238\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"952_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-016-0373-z","volume":"10","author":"P Angulo","year":"2017","unstructured":"Angulo P, Kaushik G, Subramaniam D, Dandawate P, Neville K, Chastain K, et al. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy. J Hematol Oncol. 2017;10:10.","journal-title":"J Hematol Oncol"},{"key":"952_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct Target Ther. 2024;9:1\u201346.","journal-title":"Signal Transduct Target Ther"},{"key":"952_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154902","volume":"251","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Bahonar A, Nakhaee Z, et al. New emerging targets in osteosarcoma therapy: PTEN and PI3K\/Akt crosstalk in carcinogenesis. Pathol Res Pract. 2023;251:154902.","journal-title":"Pathol Res Pract"},{"key":"952_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0837-6","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zeng X, Wang N, Zhao W, Zhang X, Teng S, et al. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Mol Cancer. 2018;17:89.","journal-title":"Mol Cancer"},{"key":"952_CR65","first-page":"365","volume":"33","author":"Y Deng","year":"2018","unstructured":"Deng Y, Zhao F, Zhang Z, Sun F, Wang M. Long noncoding RNA SNHG7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm. 2018;33:365\u201372.","journal-title":"Cancer Biother Radiopharm"},{"key":"952_CR66","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.bbrc.2018.07.137","volume":"503","author":"W Wang","year":"2018","unstructured":"Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H, et al. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139\/RUNX2 axis. Biochem Biophys Res Commun. 2018;503:1927\u201333.","journal-title":"Biochem Biophys Res Commun"},{"key":"952_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100348","volume":"27","author":"J Bu","year":"2021","unstructured":"Bu J, Guo R, Xu XZ, Luo Y, Liu JF. LncRNA SNHG16 promotes epithelial-mesenchymal transition by upregulating ITGA6 through miR-488 inhibition in osteosarcoma. J Bone Oncol. 2021;27:100348.","journal-title":"J Bone Oncol"},{"key":"952_CR68","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000495239","volume":"51","author":"C Zhu","year":"2018","unstructured":"Zhu C, Cheng D, Qiu X, Zhuang M, Liu Z. Long noncoding RNA SNHG16 promotes cell proliferation by sponging MicroRNA-205 and upregulating ZEB1 expression in osteosarcoma. Cell Physiol Biochem. 2018;51:429\u201340.","journal-title":"Cell Physiol Biochem"},{"key":"952_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"952_CR70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/dna.2018.4424","volume":"38","author":"P Su","year":"2019","unstructured":"Su P, Mu S, Wang Z. Long noncoding RNA SNHG16 promotes osteosarcoma cells migration and invasion via sponging miRNA-340. DNA Cell Biol. 2019;38:170\u20135.","journal-title":"DNA Cell Biol"},{"key":"952_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0641-9","volume":"18","author":"C Ju","year":"2018","unstructured":"Ju C, Zhou R, Sun J, Zhang F, Tang X, Chen KK, et al. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p\/SGK3 axis. Cancer Cell Int. 2018;18:141.","journal-title":"Cancer Cell Int"},{"key":"952_CR72","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s10495-021-01687-9","volume":"26","author":"S Das","year":"2021","unstructured":"Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26:512\u201333.","journal-title":"Apoptosis"},{"key":"952_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216307","volume":"570","author":"Y Qin","year":"2023","unstructured":"Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.","journal-title":"Cancer Lett"},{"key":"952_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-017-0353-9","volume":"24","author":"K Liu","year":"2017","unstructured":"Liu K, Hou Y, Liu Y, Zheng J. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. 2017;24:46.","journal-title":"J Biomed Sci"},{"key":"952_CR75","first-page":"10094","volume":"13","author":"A Zhao","year":"2021","unstructured":"Zhao A, Zhao Z, Liu W, Cui X, Wang N, Wang Y, et al. Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17. Am J Transl Res. 2021;13:10094\u2013111.","journal-title":"Am J Transl Res"},{"key":"952_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","volume":"43","author":"M He","year":"2023","unstructured":"He M, Wang Y, Xie J, Pu J, Shen Z, Wang A, et al. M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma. Oncogene. 2023;43:341\u201353.","journal-title":"Oncogene"},{"key":"952_CR77","first-page":"816","volume":"12","author":"YF Sun","year":"2022","unstructured":"Sun YF, Wang Y, Li XD, Wang H. SNHG15, a p53-regulated lncRNA, suppresses cisplatin-induced apoptosis and ROS accumulation through the miR-335-3p\/ZNF32 axis. Am J Cancer Res. 2022;12:816\u201328.","journal-title":"Am J Cancer Res"},{"key":"952_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2019.08.019","volume":"518","author":"Y Liu","year":"2019","unstructured":"Liu Y, Gu S, Li H, Wang J, Wei C, Liu Q. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression. Biochem Biophys Res Commun. 2019;518:127\u201333.","journal-title":"Biochem Biophys Res Commun"},{"key":"952_CR79","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s13018-023-04387-z","volume":"18","author":"G Li","year":"2023","unstructured":"Li G, Yan X. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p\/TP53INP1 axis. J Orthop Surg Res. 2023;18:890.","journal-title":"J Orthop Surg Res"},{"key":"952_CR80","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1515\/biol-2020-0086","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Rao D, Ma H, Kong D, Xu X, Lu H. LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p\/GFRA1 axis. Open Life Sci. 2020;15:871\u201383.","journal-title":"Open Life Sci"},{"key":"952_CR81","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.biopha.2018.07.003","volume":"106","author":"B Zhou","year":"2018","unstructured":"Zhou B, Li L, Li Y, Sun H, Zeng C. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a\/MCL1 axis. Biomed Pharmacother. 2018;106:850\u20137.","journal-title":"Biomed Pharmacother"},{"key":"952_CR82","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.path.2021.06.003","volume":"14","author":"A Yoshida","year":"2021","unstructured":"Yoshida A. Osteosarcoma: old and new challenges. Surg Pathol Clin. 2021;14:567\u201383.","journal-title":"Surg Pathol Clin"},{"key":"952_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03961-7","volume":"21","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhang C, Fang Q, Zhang W, Liu W. Abnormal signal pathways and tumor heterogeneity in osteosarcoma. J Transl Med. 2023;21:99.","journal-title":"J Transl Med"},{"key":"952_CR84","doi-asserted-by":"publisher","first-page":"155615","DOI":"10.1016\/j.prp.2024.155615","volume":"263","author":"N Heidari","year":"2024","unstructured":"Heidari N, Vosough M, Bagherifard A, Sami SH, Sarabi PA, Behmanesh A. et al. Exploring circulating MiRNA signature for osteosarcoma detection: bioinformatics-based analyzing and validation. Pathol Res Pract. 2024;263:155615","journal-title":"Pathol Res Pract"},{"key":"952_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/bios11020055","volume":"11","author":"M Barani","year":"2021","unstructured":"Barani M, Mukhtar M, Rahdar A, Sargazi S, Pandey S, Kang M. Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma. Biosensors. 2021;11:55.","journal-title":"Biosensors"},{"key":"952_CR86","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1159\/000479205","volume":"42","author":"Z Li","year":"2017","unstructured":"Li Z, Dou P, Liu T, He S. Application of long noncoding RNAs in osteosarcoma: biomarkers and therapeutic targets. Cell Physiol Biochem. 2017;42:1407\u201319.","journal-title":"Cell Physiol Biochem"},{"key":"952_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.753706","volume":"9","author":"M Wang","year":"2021","unstructured":"Wang M, Gu J, Zhang X, Yang J, Zhang X, Fang X. Long non-coding RNA DANCR in cancer: roles, mechanisms, and implications. Front Cell Dev Biol. 2021;9:753706.","journal-title":"Front Cell Dev Biol"},{"key":"952_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43246-024-00612-2","volume":"5","author":"S Kortam","year":"2024","unstructured":"Kortam S, Lu Z, Zreiqat H. Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration. Commun Mater. 2024;5:1\u201320.","journal-title":"Commun Mater"},{"key":"952_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113726","volume":"144","author":"X Zhang","year":"2025","unstructured":"Zhang X, Gao X, Xu J, Zhang Z, Lin T, Zhang X, et al. The role of lncRNA and miRNA on the effects of occurrence and development of osteosarcoma. Int Immunopharmacol. 2025;144:113726.","journal-title":"Int Immunopharmacol"},{"key":"952_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1513834","volume":"16","author":"S Qin","year":"2025","unstructured":"Qin S, Hu Y, Luo H, Chu W, Deng R, Ma J. Metal ions and nanomaterials for targeted bone cancer immunotherapy. Front Immunol. 2025;16:1513834.","journal-title":"Front Immunol"},{"key":"952_CR91","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/acs.bioconjchem.9b00028","volume":"30","author":"AM Vaidya","year":"2019","unstructured":"Vaidya AM, Sun Z, Ayat N, Schilb A, Liu X, Jiang H, et al. Systemic delivery of tumor-targeting siRNA nanoparticles against an oncogenic LncRNA facilitates effective triple-negative breast cancer therapy. Bioconjug Chem. 2019;30:907\u201319.","journal-title":"Bioconjug Chem"},{"key":"952_CR92","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1007\/s00432-023-04614-4","volume":"149","author":"S Li","year":"2023","unstructured":"Li S, Zhang H, Liu J, Shang G. Targeted therapy for osteosarcoma: a review. J Cancer Res Clin Oncol. 2023;149:6785\u201397.","journal-title":"J Cancer Res Clin Oncol"},{"key":"952_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104575","volume":"206","author":"E Adewuyi","year":"2025","unstructured":"Adewuyi E, Chorya H, Muili A, Moradeyo A, Kayode A, Naik A, et al. Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: recent advancements. Crit Rev Oncol Hematol. 2025;206:104575.","journal-title":"Crit Rev Oncol Hematol"},{"key":"952_CR94","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.7150\/ijbs.33529","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang X, Du K, Lou Z, Ding K, Zhang F, Zhu J, et al. The CtBP1-HDAC1\/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells. Int J Biol Sci. 2019;15:1460\u201371.","journal-title":"Int J Biol Sci"},{"key":"952_CR95","first-page":"6551","volume":"24","author":"W Zhang","year":"2020","unstructured":"Zhang W, Li JZ, Tai QY, Tang JJ, Huang YH, Gao SB. LncRNA DANCR regulates osteosarcoma migration and invasion by targeting miR-149\/MSI2 axis. Eur Rev Med Pharm Sci. 2020;24:6551\u201360.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"952_CR96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41417-022-00581-z","volume":"30","author":"L Li","year":"2023","unstructured":"Li L, Zhang Y, Gao Y, Hu Y, Wang R, Wang S, et al. LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 \/SLC7A11 axis in osteosarcoma cells. Cancer Gene Ther. 2023;30:704\u201315.","journal-title":"Cancer Gene Ther"},{"key":"952_CR97","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00280-019-03822-5","volume":"83","author":"S Liao","year":"2019","unstructured":"Liao S, Xing S, Ma Y. LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma. Cancer Chemother Pharm. 2019;83:1065\u201374.","journal-title":"Cancer Chemother Pharm"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00952-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00952-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00952-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:03:14Z","timestamp":1760911394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00952-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00952-2","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"type":"print","value":"0929-1903"},{"type":"electronic","value":"1476-5500"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}